These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 27025757)
21. Heterologous Expression Reveals Ancient Properties of Tei3—A VanS Ortholog from the Teicoplanin Producer Actinoplanes teichomyceticus. Yushchuk O; Zhukrovska K; Ostash B; Fedorenko V; Marinelli F Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555354 [TBL] [Abstract][Full Text] [Related]
22. Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina. Schäberle TF; Vollmer W; Frasch HJ; Hüttel S; Kulik A; Röttgen M; von Thaler AK; Wohlleben W; Stegmann E Antimicrob Agents Chemother; 2011 Sep; 55(9):4283-9. PubMed ID: 21690280 [TBL] [Abstract][Full Text] [Related]
23. Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete. Hesketh A; Bucca G; Smith CP; Hong HJ Front Microbiol; 2021; 12():641756. PubMed ID: 33717038 [TBL] [Abstract][Full Text] [Related]
24. New Molecular Tools for Regulation and Improvement of A40926 Glycopeptide Antibiotic Production in Yushchuk O; Andreo-Vidal A; Marcone GL; Bibb M; Marinelli F; Binda E Front Microbiol; 2020; 11():8. PubMed ID: 32038594 [TBL] [Abstract][Full Text] [Related]
25. Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis. Solenberg PJ; Matsushima P; Stack DR; Wilkie SC; Thompson RC; Baltz RH Chem Biol; 1997 Mar; 4(3):195-202. PubMed ID: 9115410 [TBL] [Abstract][Full Text] [Related]
30. Alternative Pathway to a Glycopeptide-Resistant Cell Wall in the Balhimycin Producer Amycolatopsis balhimycina. Frasch HJ; Kalan L; Kilian R; Martin T; Wright GD; Stegmann E ACS Infect Dis; 2015 Jun; 1(6):243-52. PubMed ID: 27622740 [TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Arthur M; Depardieu F; Reynolds P; Courvalin P Mol Microbiol; 1996 Jul; 21(1):33-44. PubMed ID: 8843432 [TBL] [Abstract][Full Text] [Related]
32. Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Pootoolal J; Thomas MG; Marshall CG; Neu JM; Hubbard BK; Walsh CT; Wright GD Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8962-7. PubMed ID: 12060705 [TBL] [Abstract][Full Text] [Related]
39. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030 [TBL] [Abstract][Full Text] [Related]
40. Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens. Das B; Sarkar C; Schachter J Pak J Pharm Sci; 2013 Sep; 26(5):1045-55. PubMed ID: 24035967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]